Why Intuitive Surgical Is a Strong Buy as Robotic Surgery Adoption Accelerates

Intuitive Surgical (ISRG) is considered a strong buy despite a recent stock decline, trading at a 20% discount to its 52-week high. The company reported robust Q1 2026 results with non-GAAP EPS of $2.50 and revenue up 23% year-over-year, driven by accelerated adoption of its da Vinci 5 systems. Analysts at 24/7 Wall St. set a price target of $615.93, indicating a 28% upside potential as robotic surgery adoption continues to grow.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin